Andrew Robbins
Director Ejecutivo en COGENT BIOSCIENCES, INC. .
Fortuna: - $ al 31/05/2024
Perfil
Andrew R.
Robbins is currently the President, Chief Executive Officer & Director at Cogent Biosciences, Inc. and an Independent Director at Turmeric Acquisition Corp.
He previously served as a Director at Cytograft Tissue Engineering, Inc., StemCor Systems, Inc., and Fate Therapeutics, Inc. From 2020 to 2024, he was an Independent Director at Harpoon Therapeutics, Inc. Prior to that, he was the Chief Operating Officer at Array BioPharma, Inc. from 2015 to 2019.
He also held the position of General Manager & Vice President at Hospira, Inc. from 2007 to 2012 and Senior Vice President-Commercial Operations at Pfizer Inc. from 2012 to 2015.
Mr. Robbins completed his undergraduate degree at Swarthmore College and holds an MBA from Kellogg School of Management.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
COGENT BIOSCIENCES, INC.
-.--% | 19/03/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Cargos activos de Andrew Robbins
| Empresas | Cargo | Inicio |
|---|---|---|
| TURMERIC ACQUISITION CORP. | Director/Miembro de la Junta | 01/10/2020 |
| COGENT BIOSCIENCES, INC. | Director Ejecutivo | 23/10/2020 |
Antiguos cargos conocidos de Andrew Robbins.
| Empresas | Cargo | Fin |
|---|---|---|
| HARPOON THERAPEUTICS, INC. | Director/Miembro de la Junta | 11/03/2024 |
| ARRAY TECHNOLOGIES, INC. | Director de Operaciones | 01/01/2019 |
| PFIZER, INC. | Director de Operaciones | 01/03/2015 |
| HOSPIRA, INC. | Corporate Officer/Principal | 01/07/2012 |
StemCor Systems, Inc.
 StemCor Systems, Inc. Medical SpecialtiesHealth Technology StemCor Systems, Inc. develops proprietary and minimally-invasive bone marrow collection systems for regenerative medicine. Its products include MarrowMiner System and MarrowSelect. The company was founded in June 2003 by Daniel Kraft and is headquartered in Menlo Park, CA. | Director/Miembro de la Junta | - |
Formación de Andrew Robbins.
| Swarthmore College | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| COGENT BIOSCIENCES, INC. | Health Technology |
| FATE THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 6 |
|---|---|
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Hospira, Inc.
 Hospira, Inc. Pharmaceuticals: MajorHealth Technology Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL. | Health Technology |
Cytograft Tissue Engineering, Inc.
 Cytograft Tissue Engineering, Inc. Pharmaceuticals: MajorHealth Technology Cytograft Tissue Engineering, Inc. engages in the development of cardiovascular medicine. It offers novel cell-based therapies to repair and rebuild diseased tissues and organ without using synthetic biomaterials. The company was founded by Todd N. McAllister and Nicolas L'Heureux in 2000 and is headquartered in Novato, CA. | Health Technology |
StemCor Systems, Inc.
StemCor Systems, Inc. Medical SpecialtiesHealth Technology StemCor Systems, Inc. develops proprietary and minimally-invasive bone marrow collection systems for regenerative medicine. Its products include MarrowMiner System and MarrowSelect. The company was founded in June 2003 by Daniel Kraft and is headquartered in Menlo Park, CA. | Health Technology |
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The firm utilizes its proprietary Tri-specific T cell Activating Construct platform to create a pipeline of novel TriTACs for the treatment of solid tumors and hematologic malignancies. The company was founded by Patrick A. Baeuerle, Luke B. Evnin, and Jeanmarie Guenot on March 19, 2015 and is headquartered in South San Francisco, CA. | Health Technology |
Turmeric Acquisition Corp.
 Turmeric Acquisition Corp. Financial ConglomeratesFinance Turmeric Acquisition Corp. operates as a blank check company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on August 28, 2020 and is headquartered in Cambridge, MA. | Finance |
- Bolsa de valores
- Insiders
- Andrew Robbins
